IBO — Universal Ibogaine Cashflow Statement
0.000.00%
Last trade - 00:00- CA$7.72m
- CA$10.04m
- CA$2.33m
Annual cashflow statement for Universal Ibogaine, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.
2022 July 31st | 2023 July 31st | 2024 July 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -10.5 | -2.39 | -2.05 |
| Depreciation | |||
| Non-Cash Items | 6.4 | 0.5 | 1.1 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.508 | 0.497 | -0.229 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -4.33 | -1.1 | -0.839 |
| Capital Expenditures | -0.096 | -0.36 | -0.079 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -1.99 | — | — |
| Acquisition of Business | |||
| Sale of Business | |||
| Sale of Fixed Assets | |||
| Cash from Investing Activities | -2.09 | -0.36 | -0.079 |
| Financing Cash Flow Items | 5.71 | 0.806 | -0.013 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 7.01 | 1.04 | 0.975 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0.584 | -0.413 | 0.058 |